Pricing Log in Create free account

Akanda Corp. (AKAN) vs Sunshine Biopharma, Inc. (SBFM)

Akanda Corp. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $3.5M against $990.0K — 3.5× the size. Across the 10 metrics below, Akanda Corp. leads on 7 and Sunshine Biopharma, Inc. on 3.

Valuation

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
P/E — n/m 19.25
P/S n/m 0.01 2.11
P/B n/m 0.01 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 2.38 12.58
EV/Sales n/m (0.33) 2.73
Earnings yield — (4,613.64%) (4.38%)
Free cash flow yield 0.00% (1,843.25%) 0.00%

Profitability

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Gross margin — 30.30% 53.94%
Operating margin — (16.65%) 0.00%
Net margin — (16.50%) 0.00%
Free cash flow margin 0.00% (15.66%) 0.00%
Return on equity 0.00% (21.93%) (0.40%)
Return on assets 0.00% (17.78%) (3.32%)
Return on invested capital 0.00% (26.67%) 0.00%

Growth

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (2.74%) 10.01%
EPS growth (last fiscal year) (139.63%) 80.33% 49.06%
Revenue growth, 5-year CAGR 161.77% 247.74% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.00 0.05
Current ratio 0.22 5.46 2.31
Net debt to EBITDA (2.75) 2.20 0.97

Dividend

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Market cap 3.45m 990.00k 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack